AQUILA BIOPHARMACEUTICALS INC (AQLA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AQUILA BIOPHARMACEUTICALS INC (AQLA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AurumRabosa who wrote (24)	4/23/2000 9:30:00 PM
From: Arthur Radley	Read Replies (2) of 45

Ron, There are a few cows here in Texas, but I like the fact the trials for this study are being done in Wisconsin. I also like the fact that the Wisconsin Investment Board(State Employees) has invested "big-time" in AQLA. One would think that they have some direct contact with the University of Wisconsin group that is conducting the test. Originally, they were to have the results available for release this month. However, in talking with the company last week, it appears the release of data will not occur until early April. I don't like delays...however, maybe the amount(data) was unexpected and is causing this delay. Granted! The approval of this drug will give AQLA an immediate source of revenue, but what I think will be the next catalyst will be the results expected from BMY/Progenics by the end of the year for their melanoma drug. These results will be the first true test for their Stimulon product as an adjuvant....and then we must remember that AQLA has several other projects with some of the majors. Now we are talking major revenue potential and a 3.00 stock price should be a distant memory.(:>) I HOPE!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next